Abstract: A process for preparing vinyl acetate-ethylene copolymers in the form of an aqueous dispersion. The process includes providing an aqueous dispersion of vinyl acetate-ethylene copolymers and subjecting the aqueous dispersion of vinyl acetate-ethylene copolymers to radically initiated emulsion polymerization in a continuously operated tubular-reactor. Where one or more dividing plates bearing liquid-permeable openings that are mounted within the tubular-reactor transverse to the flow direction of the reactor contents.

Abstract: The invention relates to a method for removing oxygen from hydrocarbon-containing gas mixtures, characterized in that a hydrocarbon-containing gas mixture containing 50 vol % of one or more hydrocarbons, 2 to 10 vol % of oxygen, and possibly one or more gases from the group comprising nitrogen, noble gases, hydrogen, carbon dioxide, carbon monoxide, and water is introduced into an isothermally operated reactor, in which the oxygen contained in the hydrocarbon-containing gas mixture is at least partially converted into carbon dioxide and water in the presence of one or more catalysts, wherein the specifications in vol % relate to the total volume of the hydrocarbon-containing gas mixture introduced into the reactor and add up to 100 vol % in total.

Abstract: A carboxylic acid is transvinylated with vinyl ester to give a vinyl ester product and the corresponding acid of the vinyl ester in the presence of a catalyst, at a temperature of 100° C. to 170° C. and a pressure of 2 bar abs. to 15 bar abs., wherein the vinyl ester, the carboxylic acid and the catalyst are supplied to a reactor, the transvinylation reaction is conducted, and, on the completion of the transvinylation, the vinyl ester product is separated from the reaction mixture by distillation, characterized in that the reaction mixture is decompressed in a decompression vessel, the gaseous phase obtained is condensed and recycled into the reactor without further purification, and the liquid phase obtained is freed of vinyl ester and corresponding acid with a first distillation, and the vinyl ester product is separated from the reaction mixture in a further distillation step.

Abstract: A carboxylic acid is transvinylated with vinyl ester to give a vinyl ester product and the corresponding acid of the vinyl ester in the presence of a catalyst, at a temperature of 100° C. to 170° C. and a pressure of 2 bar abs. to 15 bar abs., wherein the vinyl ester, the carboxylic acid and the catalyst are supplied to a reactor, the transvinylation reaction is conducted, and, on the completion of the transvinylation, the vinyl ester product is separated from the reaction mixture by distillation, characterized in that the reaction mixture is decompressed in a decompression vessel, the gaseous phase obtained is condensed and recycled into the reactor without further purification, and the liquid phase obtained is freed of vinyl ester and corresponding acid with a first distillation, and the vinyl ester product is separated from the reaction mixture in a further distillation step.

Abstract: The invention relates to the use of certain micro-RNAs circulating in the blood serum or blood plasma in the form of diagnostic profiles as a marker in an in vitro method for distinguishing between patients for which a myocardial biopsy is necessary for the diagnostic identification of a heart muscle disease and patients for which myocardial biopsy is not necessary, and for the optional differential diagnosis of individual non-ischemic cardiomyopathies or storage diseases affecting the heart.

Abstract: The invention relates to a method for removing oxygen from hydrocarbon-containing gas mixtures, characterized in that a hydrocarbon-containing gas mixture containing 50 vol % of one or more hydrocarbons, 2 to 10 vol % of oxygen, and possibly one or more gases from the group comprising nitrogen, noble gases, hydrogen, carbon dioxide, carbon monoxide, and water is introduced into an isothermally operated reactor, in which the oxygen contained in the hydrocarbon-containing gas mixture is at least partially converted into carbon dioxide and water in the presence of one or more catalysts, wherein the specifications in vol % relate to the total volume of the hydrocarbon-containing gas mixture introduced into the reactor and add up to 100 vol % in total.

Abstract: A method comprises the steps of determining that at least one message of a set of electronically formatted messages previously received by and stored in a memory of an electronic computing device was selected for removal from the electronic computing device; determining that a removal command associated with the message input into the electronic computing device through a user interface of the electronic computing device; graphically depicting destruction of the message by presenting a destruction animation on a visual human-computer interface; and removing the message from the set of electronically formatted messages.

Abstract: A process for the preparation of vinyl acetate by a heterogeneously catalysed, continuous gas-phase reaction of ethylene, acetic acid and oxygen in a reactor, where process heat liberated during the reaction is removed from the reactor by means of heat exchange with water, generating intrinsic steam, the product mixture leaving the reactor and comprising ethylene, vinyl acetate, acetic acid, water, carbon dioxide and inert gases is separated by distillation using one or more azeotrope columns and/or one or more pure distillation columns, wherein at least one azeotrope column and/or pure distillation column contains packings, and intrinsic steam is used at least partially for introducing energy into the thus-equipped azeotrope columns and/or pure distillation columns.

Abstract: An endovascular implant, comprising an at least sectional active coating (8) in which a (re)stenosis-inhibiting substance (10) based on a ratjadone derivative is embedded.

Abstract: The present invention relates to pharmaceutical compositions comprising a therapeutically effective dose of an isolated interferon (IFN) or IFN mutein for treatment of cardiomyopathy and of endothelial dysfunction, and to methods of treating cardiomyopathy and methods of treating endothelial dysfunction using such pharmaceutical compositions. Particularly, the pharmaceutical compositions of the present invention comprise a therapeutically effective dose of an isolated, human IFN, or IFN mutein that is a variant of an isolated human IFN, e.g., an isolated, native, human IFN? or an isolated, native, human IFN?.

Abstract: In a process for the partial desalination of water, especially of drinking water, with a mixture of weakly acid cation exchangers and strongly basic anion exchangers, whereby the charged ion exchangers are regenerated by CO.sub.2 -containing water, if required, with the addition of CaCO.sub.3, CaCO.sub.3 /MgO, Ca(OH).sub.2 or the like. Simultaneous with the partial desalination, the organic carbon compounds present in the water are reduced, whereby the charged ion exchangers are intermittently regenerated with HCl, NaCl, NaOH, or a mixture of NaCl and NaOH.

Abstract: An interproximal brush handle including a grip portion and an end portion and a transverse hole for accommodating a stem of an interproximal brush. The brush stem is retained securely in a longitudinal groove on closure of a cap which is pivotally attached to the end portion.